Skip to main content

Advertisement

SpringerLink
Log in

Nuclear Factor κB Signaling in Opioid Functions and Receptor Gene Expression

  • Invited Review
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Opiates are the most powerful of all known analgesics. The prototype opiate morphine has been used as a painkiller for several thousand years. Chronic usage of opiates not only causes drug tolerance, dependence, and addiction, but also suppresses immune functions and affects cell proliferation and cell survival. The diverse functions of opiates underscore the complexity of opioid receptor signaling. Several downstream signaling effector systems, including adenylyl cyclase, mitogen-activated protein kinase, Ca2+ channels, K+ channels, and phosphatidylinositol 3-kinase/Akt, have been identified to be critical in opioid functions. Nuclear factor-κB (NF-κB), one of the most diverse and critical transcription factors, is one of the downstream molecules that may either directly or indirectly transmit the receptor-mediated upstream signals to the nucleus, resulting in the regulation of the NF-κB-dependent genes, which are critical for the opioid-induced biological responses of neuronal and immune cells. In this minireview, we focus on current understanding of the involvement of NF-κB signaling in opioid functions and receptor gene expression in cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ai W, Gong J, Yu L (1999) MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway. FEBS Lett 456:196–200

    PubMed  CAS  Google Scholar 

  • Augustin LB, Felsheim RF, Min BH, Fuchs SM, Fuchs JA, Loh HH (1995) Genomic structure of the mouse delta opioid receptor gene. Biochem Biophys Res Commun 207:111–119

    PubMed  CAS  Google Scholar 

  • Azuma Y, Ohura K (2002) Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol 56:260–269

    PubMed  CAS  Google Scholar 

  • Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13–20

    PubMed  CAS  Google Scholar 

  • Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92: 9328–9332

    PubMed  CAS  Google Scholar 

  • Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720–723

    PubMed  CAS  Google Scholar 

  • Borlongan CV, Wang Y, Su TP (2004) Delta opioid peptide (d-Ala 2, d-Leu 5) enkephalin: linking hibernation and neuroprotection. Front Biosci 9:3392–3398

    PubMed  CAS  Google Scholar 

  • Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297–305

    PubMed  CAS  Google Scholar 

  • Capasso A (2001) Involvement of nuclear factor-κB in the expression of opiate withdrawal. Prog Neuro-psychopharmacol Biol Psychiatry 25:1259–1268

    CAS  Google Scholar 

  • Carr DJ, Carpenter GW, Garza HH Jr, France CP, Prakash OM (1995) Chronic and infrequent opioid exposure suppresses IL-2R expression on rhesus monkey peripheral blood mononuclear cells following stimulation with pokeweed mitogen. Int J Neurosci 81:137–148

    PubMed  CAS  Google Scholar 

  • Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272:542–545

    PubMed  CAS  Google Scholar 

  • Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401

    PubMed  CAS  Google Scholar 

  • Chen Y, Mestek A, Liu J, Yu L (1993) Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J 295(Pt 3):625–628

    PubMed  CAS  Google Scholar 

  • Chen YL, Law PY, Loh HH (2006) Sustained activation of phosphatidylinositol 3-kinase/akt/nuclear factor {kappa}B signaling mediates G protein-coupled {delta}-opioid receptor gene expression. J Biol Chem 281:3067–3074

    PubMed  CAS  Google Scholar 

  • Chuang LF, Killam KF Jr, Chuang RY (1997) Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J Biol Chem 272:26815–26817

    PubMed  CAS  Google Scholar 

  • Colasanti M, Persichini T (2000) Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells. Brain Res Bull 52:155–161

    PubMed  CAS  Google Scholar 

  • Collier HO, Francis DL (1975) Morphine abstinence is associated with increased brain cyclic AMP. Nature 255:159–162

    PubMed  CAS  Google Scholar 

  • Conant K, Ma M, Nath A, Major EO (1996) Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 70:1384–1389

    PubMed  CAS  Google Scholar 

  • Czlonkowski A, Stein C, Herz A (1993) Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur J Pharmacol 242:229–235

    PubMed  CAS  Google Scholar 

  • DelaTorre A, Schroeder RA, Kuo PC (1997) Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 238:703–706

    PubMed  CAS  Google Scholar 

  • Dixit V, Mak TW (2002) NF-kappaB signaling. Many roads lead to madrid. Cell 111:615–619

    PubMed  CAS  Google Scholar 

  • Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952–1955

    PubMed  CAS  Google Scholar 

  • Fischer EG (1988) Opioid peptides modulate immune functions. A review. Immunopharmacol Immunotoxicol 10:265–326

    PubMed  CAS  Google Scholar 

  • Fukuda K, Kato S, Mori K, Nishi M, Takeshima H (1993) Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett 327:311–314

    PubMed  CAS  Google Scholar 

  • Fukuda K, Kato S, Morikawa H, Shoda T, Mori K (1996) Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67:1309–1316

    Article  PubMed  CAS  Google Scholar 

  • Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell 14:303–317

    PubMed  CAS  Google Scholar 

  • Gaveriaux C, Peluso J, Simonin F, Laforet J, Kieffer B (1995) Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett 369:272–276

    PubMed  CAS  Google Scholar 

  • Gaveriaux-Ruff C, Matthes HW, Peluso J, Kieffer BL (1998) Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci USA 95:6326–6330

    PubMed  CAS  Google Scholar 

  • Georges F, Normand E, Bloch B, Le Moine C (1998) Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Brain Res Dev Brain Res 109:187–199

    PubMed  CAS  Google Scholar 

  • Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81–S96

    PubMed  CAS  Google Scholar 

  • Guerrini L, Blasi F, Denis-Donini S (1995) Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA 92:9077–9081

    PubMed  CAS  Google Scholar 

  • Henry DJ, Grandy DK, Lester HA, Davidson N, Chavkin C (1995) Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Mol Pharmacol 47:551–557

    PubMed  CAS  Google Scholar 

  • Hirano F, Tanaka H, Hirano Y, Hiramoto M, Handa H, Makino I, Scheidereit C (1998) Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol Cell Biol 18:1266–1274

    PubMed  CAS  Google Scholar 

  • Hou YN, Vlaskovska M, Cebers G, Kasakov L, Liljequist S, Terenius L (1996) A mu-receptor opioid agonist induces AP-1 and NF-kappa B transcription factor activity in primary cultures of rat cortical neurons. Neurosci Lett 212:159–162

    PubMed  CAS  Google Scholar 

  • Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66:285–306

    PubMed  CAS  Google Scholar 

  • Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048–12052

    PubMed  CAS  Google Scholar 

  • Kraus J, Borner C, Giannini E, Hollt V (2003) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64:876–884

    PubMed  CAS  Google Scholar 

  • Law PY, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389–430

    PubMed  CAS  Google Scholar 

  • Law PY, Loh HH, Wei LN (2004) Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47(Suppl 1):300–311

    PubMed  CAS  Google Scholar 

  • Lawrence DM, el-Hamouly W, Archer S, Leary JF, Bidlack JM (1995) Identification of kappa opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci USA 92:1062–1066

    PubMed  CAS  Google Scholar 

  • Lezoualc'h F, Sagara Y, Holsboer F, Behl C (1998) High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J Neurosci 18:3224–3232

    PubMed  Google Scholar 

  • Li LY, Chang KJ (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol Pharmacol 50:599–602

    PubMed  CAS  Google Scholar 

  • Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734

    PubMed  CAS  Google Scholar 

  • Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, Liu-Chen LY (1993) Molecular cloning and expression of a rat kappa opioid receptor. Biochem J 295(Pt 3):629–633

    PubMed  CAS  Google Scholar 

  • Li MD, McAllen K, Sharp BM (1999) Regulation of delta opioid receptor expression by anti-CD3-epsilon, PMA, and ionomycin in murine splenocytes and T cells. J Leukoc Biol 65:707–714

    PubMed  CAS  Google Scholar 

  • Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ (2003) Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 163:1167–1175

    PubMed  CAS  Google Scholar 

  • Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K (1997) The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159:4952–4958

    PubMed  CAS  Google Scholar 

  • Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB (1996) Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 156:4845–4850

    PubMed  CAS  Google Scholar 

  • Maggirwar SB, Sarmiere PD, Dewhurst S, Freeman RS (1998) Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci 18:10356–10365

    PubMed  CAS  Google Scholar 

  • Marshall HE, Hess DT, Stamler JS (2004) S-Nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci USA 101:8841–8842

    PubMed  CAS  Google Scholar 

  • Matthews JR, Botting CH, Panico M, Morris HR, Hay RT (1996) Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 24:2236–2242

    PubMed  CAS  Google Scholar 

  • Mattson MP (2003) Insulating axons via NF-kappaB. Nat Neurosci 6:105–106

    PubMed  CAS  Google Scholar 

  • McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111–123

    PubMed  CAS  Google Scholar 

  • Meffert MK, Baltimore D (2005) Physiological functions for brain NF-kappaB. Trends Neurosci 28:37–43

    PubMed  CAS  Google Scholar 

  • Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D (2003) NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6:1072–1078

    PubMed  CAS  Google Scholar 

  • Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci USA 90:9954–9958

    PubMed  CAS  Google Scholar 

  • Middleton G, Wyatt S, Ninkina N, Davies AM (2001) Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival. Development 128:447–457

    PubMed  CAS  Google Scholar 

  • Miyamae T, Fukushima N, Misu Y, Ueda H (1993) Delta opioid receptor mediates phospholipase C activation via Gi in Xenopus oocytes. FEBS Lett 333:311–314

    PubMed  CAS  Google Scholar 

  • Murphy TJ (2003) Simple nuclear factor kappaB-mediated mu-opioid receptor induction in immune cells. Mol Pharmacol 64:796–797

    PubMed  CAS  Google Scholar 

  • Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 93:9090–9095

    PubMed  CAS  Google Scholar 

  • Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439–2450

    PubMed  CAS  Google Scholar 

  • Nestler EJ (1997) Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7:713–719

    PubMed  CAS  Google Scholar 

  • Nestler EJ (2004) Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210–218

    PubMed  CAS  Google Scholar 

  • Nickols JC, Valentine W, Kanwal S, Carter BD (2003) Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 6:161–167

    PubMed  CAS  Google Scholar 

  • O'Neill LA, Kaltschmidt C (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252–258

    PubMed  Google Scholar 

  • Ozawa T, Nakagawa T, Minami M, Satoh M (1999) Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein. Neurosci Lett 267:117–120

    PubMed  CAS  Google Scholar 

  • Park SW, Wei LN (2003) Regulation of c-myc gene by nitric oxide via inactivating NF-kappa B complex in P19 mouse embryonal carcinoma cells. J Biol Chem 278:29776–29782

    PubMed  CAS  Google Scholar 

  • Park SW, Li J, Loh HH, Wei LN (2002) A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene. J Neurosci 22:7941–7947

    PubMed  CAS  Google Scholar 

  • Park SW, Huq MD, Hu X, Wei LN (2005) Tyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB. Mol Cell Proteomics 4:300–309

    PubMed  CAS  Google Scholar 

  • Parry GC, Mackman N (1997) Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol 159:5450–5456

    PubMed  CAS  Google Scholar 

  • Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M (2006) Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut 55:815–823

    PubMed  CAS  Google Scholar 

  • Piros ET, Prather PL, Loh HH, Law PY, Evans CJ, Hales TG (1995) Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol Pharmacol 47:1041–1049

    PubMed  CAS  Google Scholar 

  • Pol O, Alameda F, Puig MM (2001) Inflammation enhances mu-opioid receptor transcription and expression in mice intestine. Mol Pharmacol 60:894–899

    PubMed  CAS  Google Scholar 

  • Polakiewicz RD, Schieferl SM, Dorner LF, Kansra V, Comb MJ (1998a) A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J Biol Chem 273:12402–12406

    PubMed  CAS  Google Scholar 

  • Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, Comb MJ (1998b) mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273:23534–23541

    PubMed  CAS  Google Scholar 

  • Pomerantz JL, Baltimore D (2002) Two pathways to NF-kappaB. Mol Cell 10:693–695

    PubMed  CAS  Google Scholar 

  • Prather PL, Loh HH, Law PY (1994) Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol 45:997–1003

    PubMed  CAS  Google Scholar 

  • Rogers TJ, Peterson PK (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24:116–121

    PubMed  CAS  Google Scholar 

  • Rojo AI, Salinas M, Martin D, Perona R, Cuadrado A (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24:7324–7334

    PubMed  CAS  Google Scholar 

  • Roy S, Barke RA, Loh HH (1998a) Mu-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 61:190–194

    PubMed  CAS  Google Scholar 

  • Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA (1998b) Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun 245:392–396

    PubMed  CAS  Google Scholar 

  • Rozenfeld-Granot G, Toren A, Amariglio N, Nagler A, Rosenthal E, Biniaminov M, Brok-Simoni F, Rechavi G (2002) MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(−) cells. Exp Hematol 30:473–480

    PubMed  CAS  Google Scholar 

  • Salzet M, Vieau D, Day R (2000) Crosstalk between nervous and immune systems through the animal kingdom: focus on opioids. Trends Neurosci 23:550–555

    PubMed  CAS  Google Scholar 

  • Schmitz R (1985) Friedrich Wilhelm Serturner and the discovery of morphine. Pharm Hist 27:61–74

    PubMed  CAS  Google Scholar 

  • Shahabi NA, McAllen K, Matta SG, Sharp BM (2000) Expression of delta opioid receptors by splenocytes from SEB-treated mice and effects on phosphorylation of MAP kinase. Cell Immunol 205:84–93

    PubMed  CAS  Google Scholar 

  • Sharma SK, Klee WA, Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092–3096

    PubMed  CAS  Google Scholar 

  • Sharp BM (2003) Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv Exp Med Biol 521:98–105

    PubMed  CAS  Google Scholar 

  • Sheng WS, Hu S, Lokensgard JR, Peterson PK (2003) U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol 65:9–14

    PubMed  CAS  Google Scholar 

  • Sibinga NE, Goldstein A (1988) Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 6:219–249

    PubMed  CAS  Google Scholar 

  • Smart D, Hirst RA, Hirota K, Grandy DK, Lambert DG (1997) The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase. Br J Pharmacol 120:1165–1171

    PubMed  CAS  Google Scholar 

  • Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217–1281

    PubMed  CAS  Google Scholar 

  • Standifer KM, Pasternak GW (1997) G proteins and opioid receptor-mediated signalling. Cell Signal 9:237–248

    PubMed  CAS  Google Scholar 

  • Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS (1995) Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 270:30290–30293

    PubMed  CAS  Google Scholar 

  • Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, Herz A (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87:5935–5939

    PubMed  CAS  Google Scholar 

  • Sun P, Loh HH (2002) Transcriptional regulation of mouse delta-opioid receptor gene. Role of Ikaros in the stimulated transcription of mouse delta-opioid receptor gene in activated T cells. J Biol Chem 277:12854–12860

    PubMed  CAS  Google Scholar 

  • Suzuki S, Chuang TK, Chuang LF, Doi RH, Chuang RY (2001) Morphine upregulates kappa-opioid receptors of human lymphocytes. Adv Exp Med Biol 493:81–87

    Article  PubMed  CAS  Google Scholar 

  • Tallent M, Dichter MA, Bell GI, Reisine T (1994) The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells. Neuroscience 63:1033–1040

    PubMed  CAS  Google Scholar 

  • Taylor DA, Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11–18

    PubMed  CAS  Google Scholar 

  • Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52

    PubMed  CAS  Google Scholar 

  • Walker JS (2003) Anti-inflammatory effects of opioids. Adv Exp Med Biol 521:148–160

    PubMed  CAS  Google Scholar 

  • Wang J, Barke RA, Charboneau R, Loh HH, Roy S (2003) Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J Biol Chem 278:37622–37631

    PubMed  CAS  Google Scholar 

  • Wang X, Douglas SD, Commons KG, Pleasure DE, Lai J, Ho C, Bannerman P, Williams M, Ho W (2004) A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons. J Neurosci Res 75:544–553

    PubMed  CAS  Google Scholar 

  • Wang L, Reinach P, Lu L (2005) TNF-alpha promotes cell survival through stimulation of K+ channel and NFkappaB activity in corneal epithelial cells. Exp Cell Res 311:39–48

    PubMed  CAS  Google Scholar 

  • Welters ID, Fimiani C, Bilfinger TV, Stefano GB (2000a) NF-kappaB, nitric oxide and opiate signaling. Med Hypotheses 54:263–268

    PubMed  CAS  Google Scholar 

  • Welters ID, Menzebach A, Goumon Y, Cadet P, Menges T, Hughes TK, Hempelmann G, Stefano GB (2000b) Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92:1677–1684

    PubMed  CAS  Google Scholar 

  • Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299–343

    Google Scholar 

  • Wong YH, Federman A, Pace AM, Zachary I, Evans T, Pouyssegur J, Bourne HR (1991) Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation. Nature 351:63–65

    PubMed  CAS  Google Scholar 

  • Wooten MW, Vandenplas ML, Seibenhener ML, Geetha T, Diaz-Meco MT (2001) Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway. Mol Cell Biol 21:8414–8427

    PubMed  CAS  Google Scholar 

  • Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z, Su B (2001) The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2:620–624

    PubMed  CAS  Google Scholar 

  • Yasuda K, Raynor K, Kong H, Breder CD, Takeda J, Reisine T, Bell GI (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci USA 90: 6736–6740

    PubMed  CAS  Google Scholar 

  • Ye RD (2001) Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol 70:839–848

    PubMed  CAS  Google Scholar 

  • Yeh SH, Lin CH, Lee CF, Gean PW (2002) A requirement of nuclear factor-kappaB activation in fear-potentiated startle. J Biol Chem 277:46720–46729

    PubMed  CAS  Google Scholar 

  • Yeiser EC, Rutkoski NJ, Naito A, Inoue J, Carter BD (2004) Neurotrophin signaling through the p75 receptor is deficient in traf6-/- mice. J Neurosci 24:10521–10529

    PubMed  CAS  Google Scholar 

  • Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802–809

    PubMed  CAS  Google Scholar 

  • Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386:499–502

    PubMed  CAS  Google Scholar 

  • Zhang N, Oppenheim JJ (2005) Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol 78:1210–1214

    PubMed  CAS  Google Scholar 

  • Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O'Brien CP, Ho WZ (2003) Alcohol potentiates hepatitis C virus replicon expression. Hepatology 38:57–65

    PubMed  CAS  Google Scholar 

  • Zhong H, May MJ, Jimi E, Ghosh S (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625–636

    PubMed  CAS  Google Scholar 

  • Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci 18:2538–2549

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institute of Health Grants DA000564, DA001583, DA011806, DA007339, DA016674, K05-DA70554 (HHL), and K05-DA00513 (PYL), and by the A. & F. Stark Fund of the Minnesota Medical Foundation.

We apologize to many authors whose contributions could not be discussed or whose primary references could not be cited in this review due to space limitation. We also thank Susan Marriott for editorial assistance in preparation of the abstract of this revised manuscript.

Author information

Authors and Affiliations

  1. Department of Pharmacology, the University of Minnesota School of Medicine, 321 Church St. S.E., Minneapolis, MN, 55455, USA

    Yulong L. Chen, Ping-Yee Law & Horace H. Loh

Authors
  1. Yulong L. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ping-Yee Law
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Horace H. Loh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yulong L. Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Y.L., Law, PY. & Loh, H.H. Nuclear Factor κB Signaling in Opioid Functions and Receptor Gene Expression. Jrnl Neuroimmune Pharm 1, 270–279 (2006). https://doi.org/10.1007/s11481-006-9028-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-006-9028-0

Key words

Search

Navigation